Results 71 to 80 of about 32,569 (155)

Methotrexate-Associated Lymphoproliferative Disorders Characterized by a T-Cell Phenotype With Lung and Psoas Involvement: A Case Report. [PDF]

Case Rep Med
Arai K, Tokuyasu H, Sueda Y, Sakai H, Watase H, Yoshioka M, Naritomi Y, Esumi C, Yamasaki A.   +8 more
europepmc   +1 more source

EBV-Driven NK/T-Cell Lymphoproliferative Disorders: Clinical Diversity and Molecular Insights. [PDF]

Lymphatics
Luniewski A, Chaudhary S, Goldfarb A, Obiorah IE.   +3 more
europepmc   +1 more source

Analysis of Influences of Sjögren's Disease and Anti-Ro/SS-A Antibodies on Clinical Course of Patients with Rheumatoid Arthritis Complicated by Lymphoproliferative Disorders: A Pilot Study. [PDF]

J Clin Med
Horai Y, Kurushima S, Nakamura H, Kawakami A.   +3 more
europepmc   +1 more source

Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders. [PDF]

Curr Hematol Malig Rep, 2023
Oishi N, Ahmed R, Feldman AL.
europepmc   +1 more source

Artificial intelligence-based flow cytometry for the diagnosis of B-cell chronic lymphoproliferative disorders. [PDF]

Blood Adv
Mauvieux L, Herbrecht R, Eischen A, Galoisy AC, Rolland D, Gervais C, Mayeur-Rousse C, Hueber-Bonnot S, Nicolae A, Fornecker LM, Goetsch T, Severac F, Bizoï R, Fabacher T, Miguet L.   +14 more
europepmc   +1 more source

Epstein-Barr Virus Detection in Lymphoproliferative Disorders: Epidemiological Characterization in Western Mexico. [PDF]

Infect Dis Rep
Licona-Lasteros KC, Navarrete-Medina E, Franco-Topete K, Rodriguez-Preciado SY, Palomares-Marin J, Cazarez-Navarro G, Franco-Topete RA, Hernández-Cañaveral II.   +7 more
europepmc   +1 more source

Incidence of <i>de novo</i> Lymphoproliferative Disorders and Hematological Malignancies in Liver Transplant Recipients: An Updated Meta-Analysis. [PDF]

Saudi J Med Med Sci
Gadour E, Miutescu B, Kuriry H, Nica C, Abufarhaneh E, Alsheekh LA, Taheri E, AlSaeed Z, AlQahtani MS, Zarrouq S, Facciorusso A.   +10 more
europepmc   +1 more source

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders. [PDF]

Open Forum Infect Dis
Schweitzer L, Thiant S, Thérien C, Giroux M, Lachance S, Fleury I, Orio J, Carli C, Boudreau G, Patenaude J, Tremblay-Laganière C, Senécal L, Dufresne SF, Mollica L, Collette S, Sauvageau G, Kiss T, Cohen S, Bernard L, Bambace N, Veilleux O, Ahmad I, Roy J, Busque L, Duval M, Bittencourt H, Teira P, Lamarche C, Roy DC, Delisle JS.   +29 more
europepmc   +1 more source

Tocilizumab as a Potential Alternative Therapy for Acute Exacerbation of Systemic Sclerosis-Associated Interstitial Lung Disease in a Dialysis Patient Following Immunodeficiency-Associated Lymphoproliferative Disorders. [PDF]

Cureus
Kuga T, Kusaoi M, Yamaji K, Tamura N.
europepmc   +1 more source

Save or Remove the Accessory Spleen in Patient Candidates to Splenectomy for Lymphoproliferative Disorders: Rational and Literature Review. [PDF]

Clin Case Rep
Rinaldi V, Ribersani M, Giordano C, Maccioni F, Ferent IC, Nardi P, Caronna R, Saullo P.   +7 more
europepmc   +1 more source